InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-20 · accession 0001159036-26-000028 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-24 2026-02-20+ HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 +39.2K 779.9K +5% $0
DM 2026-02-24 2026-02-20+ HALO Torley Helen Pres AND CEO, Dir F - Tax $70.79 -21.1K 767.8K -3% -$1.50M
DM 2026-02-24 2026-02-20+ HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 -39.2K 50.3K -44% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-20 M A 16,757 $0.00 766,488 D — —
2 Common Common Stock 2026-02-23 M A 22,436 $0.00 779,884 D — —
3 Common Common Stock 2026-02-20 F D 9,040 $70.98 757,448 D — — (F1) The reported disposition of 9,040 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
4 Common Common Stock 2026-02-23 F D 12,104 $70.64 767,780 D — — (F2) The reported disposition of 12,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
5 Derivative Restricted Stock Units 2026-02-23 M D 22,436 $0.00 44,872 D $0.00 · — to — 22,436 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2026-02-20 M D 16,757 $0.00 50,270 D $0.00 · — to — 16,757 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.